Certified by Founder Lodge
Helex
United States - New York, NY
START UP
1 Disclosed Funding Rounds $3,500,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Helex is taking the promise of non-viral targeted delivery and genome editing to the kidney, developing first-in-class genetic medicines for renal indications. Helex combines its proprietary
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 04 ,2025 | Seed | $3,500,000 |
pi Ventures
Bluehill Capital
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Balerion AI | $6,000,000 | (Apr 17, 2026)
Solidroad | $25,000,000 | (Apr 17, 2026)
Worki.ai | $2,750,000 | (Apr 17, 2026)
Beeline Medicines | $300,000,000 | (Apr 17, 2026)
Ethermed | $8,500,000 | (Apr 17, 2026)
